The following presentation entitled "Damned Lies + Damned Statistics: Celebrating Periop Beta Blockade" was delivered by Dr Muhammad Amir Ayub of Hospital Melaka during its Journal Club session on 1 December 2022.

00:00: Don't forget to subscribe and share!
00:05: Introduction
00:00: Opening statement, err, question
01:00: The DECREASE'd guidelines
02:50: The researcher behind DECREASE and subsequent issues
06:15: AHA/ESC guidelines post DECREASE retractions
09:18: POISE1, the main antiDECREASE trial
11:10: Revised metaanalysis without DECREASE
12:12: New studies in the postDECREASE era
15:38: Outspoken voices against the establishment
16:31: Studies reviewing potential benefits of revascularization pre noncardiac surgery
19:10: Is there anything new: 2022 ESC guidelines and others
21:21: What is seen (or not seen) in "official" academic media, and lessons regarding the gold rushes to find the magic bullet
24:37: Conclusions
26:24: Should we not routinely start them for noncardiac surgery
27:04: Possible physiological fallacy between the patients with CAD and those undergoing surgery
27:41: On continuing beta blockers if already on them long term
28:03: On short acting beta blockers during induction/reversal
28:25: More comments on trying to "do something" to prevent cardiac events during noncardiac surgery

There are some minor postproduction issues that the editor has decided to not fix (in the interest of time) near the end (27:02 27:40)

Don't forget to subscribe for more upcoming videos from the channel.